메뉴 건너뛰기




Volumn 84, Issue 1, 2016, Pages 40-46.e7

Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

EID: 84959257172     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2015.12.036     Document Type: Article
Times cited : (50)

References (47)
  • 1
    • 0037123274 scopus 로고    scopus 로고
    • Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: Scientific review
    • N. Shaheen, and D.F. Ransohoff Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review JAMA 287 2002 1972 1981
    • (2002) JAMA , vol.287 , pp. 1972-1981
    • Shaheen, N.1    Ransohoff, D.F.2
  • 3
    • 13744258445 scopus 로고    scopus 로고
    • The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence
    • H. Pohl, and H.G. Welch The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 2005 142 146
    • (2005) J Natl Cancer Inst , vol.97 , pp. 142-146
    • Pohl, H.1    Welch, H.G.2
  • 4
    • 77953307285 scopus 로고    scopus 로고
    • Esophageal adenocarcinoma incidence: Are we reaching the peak?
    • H. Pohl, B. Sirovich, and H.G. Welch Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomark Prevent 19 2010 1468 1470
    • (2010) Cancer Epidemiol Biomark Prevent , vol.19 , pp. 1468-1470
    • Pohl, H.1    Sirovich, B.2    Welch, H.G.3
  • 5
    • 0036179390 scopus 로고    scopus 로고
    • Surveillance and survival in Barrett's adenocarcinomas: A population-based study
    • D.A. Corley, T.R. Levin, L.A. Habel, and et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 2002 633 640
    • (2002) Gastroenterology , vol.122 , pp. 633-640
    • Corley, D.A.1    Levin, T.R.2    Habel, L.A.3
  • 6
    • 85006179163 scopus 로고    scopus 로고
    • Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression
    • Apr 22
    • F. Kastelein, S.H. van Olphen, E.W. Steyerberg, and et al. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression Gut Epub 2015 Apr 22
    • (2015) Gut Epub
    • Kastelein, F.1    Van Olphen, S.H.2    Steyerberg, E.W.3
  • 7
    • 84980528539 scopus 로고    scopus 로고
    • Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus
    • Aug 26
    • H.B. El-Serag, A.D. Naik, Z. Duan, and et al. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus Gut Epub 2015 Aug 26
    • (2015) Gut Epub
    • El-Serag, H.B.1    Naik, A.D.2    Duan, Z.3
  • 8
    • 84905575282 scopus 로고    scopus 로고
    • Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: A population-based cohort study
    • R.E. Verbeek, M. Leenders, F.J. ten Kate, and et al. Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study Am J Gastroenterol 109 2014 1215 1222
    • (2014) Am J Gastroenterol , vol.109 , pp. 1215-1222
    • Verbeek, R.E.1    Leenders, M.2    Ten Kate, F.J.3
  • 9
    • 84880616361 scopus 로고    scopus 로고
    • Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas
    • D.A. Corley, K. Mehtani, C. Quesenberry, and et al. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas Gastroenterology 145 2013 312 319
    • (2013) Gastroenterology , vol.145 , pp. 312-319
    • Corley, D.A.1    Mehtani, K.2    Quesenberry, C.3
  • 10
    • 73549083853 scopus 로고    scopus 로고
    • Barrett's esophagus
    • P. Sharma Barrett's esophagus N Engl J Med 361 2009 2548 2556
    • (2009) N Engl J Med , vol.361 , pp. 2548-2556
    • Sharma, P.1
  • 11
    • 77954726942 scopus 로고    scopus 로고
    • Risk of malignant progression in patients with Barrett's oesophagus: A Dutch nationwide cohort study
    • P.J. de Jonge, M. Van Blankenstein, C.W. Looman, and et al. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study Gut 59 2010 1030 1036
    • (2010) Gut , vol.59 , pp. 1030-1036
    • De Jonge, P.J.1    Van Blankenstein, M.2    Looman, C.W.3
  • 12
    • 85045482804 scopus 로고    scopus 로고
    • Surveillance of Barrett's oesophagus: Exploring the uncertainty through systematic review, expert workshop and economic modelling
    • iii-iv
    • R. Garside, M. Pitt, M. Somerville, and et al. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling Health Technol Assess 10 2006 1 142 iii-iv
    • (2006) Health Technol Assess , vol.10 , pp. 1-142
    • Garside, R.1    Pitt, M.2    Somerville, M.3
  • 13
    • 84869199932 scopus 로고    scopus 로고
    • The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus
    • ASGE Standards of Practice Committee J.A. Evans, D.S. Early, N. Fukami, and et al. The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus Gastrointest Endosc 76 2012 1087 1094
    • (2012) Gastrointest Endosc , vol.76 , pp. 1087-1094
    • Evans, J.A.1    Early, D.S.2    Fukami, N.3
  • 14
    • 79960249713 scopus 로고    scopus 로고
    • Risk of malignant progression in Barrett's esophagus patients: Results from a large population-based study
    • S. Bhat, H.G. Coleman, F. Yousef, and et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study J Natl Cancer Inst 103 2011 1049 1057
    • (2011) J Natl Cancer Inst , vol.103 , pp. 1049-1057
    • Bhat, S.1    Coleman, H.G.2    Yousef, F.3
  • 15
    • 84885751662 scopus 로고    scopus 로고
    • Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: A systematic review and meta-analysis
    • S. Singh, A.N. Sharma, M.H. Murad, and et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis Clin Gastroenterol Hepatol 11 2013 1399 1412
    • (2013) Clin Gastroenterol Hepatol , vol.11 , pp. 1399-1412
    • Singh, S.1    Sharma, A.N.2    Murad, M.H.3
  • 16
    • 4544342836 scopus 로고    scopus 로고
    • Risk stratification of Barrett's esophagus: Updated prospective multivariate analysis
    • A.P. Weston, P. Sharma, S. Mathur, and et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis Am J Gastroenterol 99 2004 1657 1666
    • (2004) Am J Gastroenterol , vol.99 , pp. 1657-1666
    • Weston, A.P.1    Sharma, P.2    Mathur, S.3
  • 17
    • 84889668102 scopus 로고    scopus 로고
    • Barrett's oesophagus: Epidemiology, cancer risk and implications for management
    • P.J. de Jonge, M. van Blankenstein, W.M. Grady, and et al. Barrett's oesophagus: epidemiology, cancer risk and implications for management Gut 63 2014 191 202
    • (2014) Gut , vol.63 , pp. 191-202
    • De Jonge, P.J.1    Van Blankenstein, M.2    Grady, W.M.3
  • 18
    • 79960069342 scopus 로고    scopus 로고
    • Predictors for neoplastic progression in patients with Barrett's Esophagus: A prospective cohort study
    • M. Sikkema, C. Looman, E. Steyerberg, and et al. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study Am J Gastroenterol 106 2011 1231 1238
    • (2011) Am J Gastroenterol , vol.106 , pp. 1231-1238
    • Sikkema, M.1    Looman, C.2    Steyerberg, E.3
  • 19
    • 28044459843 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: A prospective study
    • T.L. Vaughan, L.M. Dong, P.L. Blount, and et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study Lancet Oncol 6 2005 945 952
    • (2005) Lancet Oncol , vol.6 , pp. 945-952
    • Vaughan, T.L.1    Dong, L.M.2    Blount, P.L.3
  • 20
    • 84861722871 scopus 로고    scopus 로고
    • Aspirin and cancer risk: A quantitative review to 2011
    • C. Bosetti, V. Rosato, S. Gallus, and et al. Aspirin and cancer risk: a quantitative review to 2011 Ann Oncol 23 2012 1403 1415
    • (2012) Ann Oncol , vol.23 , pp. 1403-1415
    • Bosetti, C.1    Rosato, V.2    Gallus, S.3
  • 21
    • 84899918312 scopus 로고    scopus 로고
    • Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: A meta-analysis
    • S. Zhang, X.Q. Zhang, X.W. Ding, and et al. Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysis Br J Cancer 110 2014 2378 2388
    • (2014) Br J Cancer , vol.110 , pp. 2378-2388
    • Zhang, S.1    Zhang, X.Q.2    Ding, X.W.3
  • 22
    • 84859386286 scopus 로고    scopus 로고
    • Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus
    • E.D. Kantor, L. Onstad, P.L. Blount, and et al. Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus Cancer Epidemiol Biomark Prevent 21 2012 456 461
    • (2012) Cancer Epidemiol Biomark Prevent , vol.21 , pp. 456-461
    • Kantor, E.D.1    Onstad, L.2    Blount, P.L.3
  • 23
    • 81855167480 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus
    • F. Kastelein, M.C. Spaander, K. Biermann, and et al. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus Gastroenterology 141 2011 2000 2008
    • (2011) Gastroenterology , vol.141 , pp. 2000-2008
    • Kastelein, F.1    Spaander, M.C.2    Biermann, K.3
  • 24
    • 84864031678 scopus 로고    scopus 로고
    • Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma
    • I.L. Beales, I. Vardi, and L. Dearman Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma Eur J Gastroenterol Hepatol 24 2012 917 923
    • (2012) Eur J Gastroenterol Hepatol , vol.24 , pp. 917-923
    • Beales, I.L.1    Vardi, I.2    Dearman, L.3
  • 25
    • 77952837521 scopus 로고    scopus 로고
    • Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus
    • D.M. Nguyen, P. Richardson, and H.B. El-Serag Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus Gastroenterology 138 2010 2260 2266
    • (2010) Gastroenterology , vol.138 , pp. 2260-2266
    • Nguyen, D.M.1    Richardson, P.2    El-Serag, H.B.3
  • 26
    • 84878135553 scopus 로고    scopus 로고
    • Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: A systematic review and meta-analysis
    • S. Singh, A.G. Singh, P.P. Singh, and et al. Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis Clin Gastroenterol Hepatol 11 2013 620 629
    • (2013) Clin Gastroenterol Hepatol , vol.11 , pp. 620-629
    • Singh, S.1    Singh, A.G.2    Singh, P.P.3
  • 27
    • 7044232109 scopus 로고    scopus 로고
    • Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus
    • H.B. El-Serag, T.V. Aguirre, S. Davis, and et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus Am J Gastroenterol 99 2004 1877 1883
    • (2004) Am J Gastroenterol , vol.99 , pp. 1877-1883
    • El-Serag, H.B.1    Aguirre, T.V.2    Davis, S.3
  • 28
    • 1942500137 scopus 로고    scopus 로고
    • Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
    • L.C. Hillman, L. Chiragakis, B. Shadbolt, and et al. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus Med J Australia 180 2004 387 391
    • (2004) Med J Australia , vol.180 , pp. 387-391
    • Hillman, L.C.1    Chiragakis, L.2    Shadbolt, B.3
  • 29
    • 14344253639 scopus 로고    scopus 로고
    • Barrett's oesophagus and oesophageal adenocarcinoma: How does acid interfere with cell proliferation and differentiation?
    • R. Fitzgerald Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? Gut 54 2005 i21 i26
    • (2005) Gut , vol.54 , pp. i21-i26
    • Fitzgerald, R.1
  • 30
    • 84875365855 scopus 로고    scopus 로고
    • Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus
    • F. Kastelein, M.C. Spaander, E.W. Steyerberg, and et al. Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus Clin Gastroenterol Hepatol 11 2013 382 388
    • (2013) Clin Gastroenterol Hepatol , vol.11 , pp. 382-388
    • Kastelein, F.1    Spaander, M.C.2    Steyerberg, E.W.3
  • 31
    • 84904039736 scopus 로고    scopus 로고
    • Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: A systematic review and meta-analysis
    • S. Singh, S.K. Garg, P.P. Singh, and et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis Gut 63 2014 1229 1237
    • (2014) Gut , vol.63 , pp. 1229-1237
    • Singh, S.1    Garg, S.K.2    Singh, P.P.3
  • 32
    • 0025856399 scopus 로고
    • Validation of information recorded on general practitioner based computerised data resource in the United Kingdom
    • H. Jick, S.S. Jick, and L.E. Derby Validation of information recorded on general practitioner based computerised data resource in the United Kingdom BMJ 302 1991 766
    • (1991) BMJ , vol.302 , pp. 766
    • Jick, H.1    Jick, S.S.2    Derby, L.E.3
  • 33
    • 20444502054 scopus 로고    scopus 로고
    • Type 2 diabetes mellitus and the risk of colorectal cancer
    • Y.-X. Yang, S. Hennessy, and J.D. Lewis Type 2 diabetes mellitus and the risk of colorectal cancer Clin Gastroenterol Hepatol 3 2005 587 594
    • (2005) Clin Gastroenterol Hepatol , vol.3 , pp. 587-594
    • Yang, Y.-X.1    Hennessy, S.2    Lewis, J.D.3
  • 34
    • 84882263647 scopus 로고    scopus 로고
    • Association of Barrett's esophagus with type II diabetes mellitus: Results from a large population-based case-control study
    • P.G. Iyer, B.J. Borah, H.C. Heien, and et al. Association of Barrett's esophagus with type II diabetes mellitus: results from a large population-based case-control study Clin Gastroenterol Hepatol 11 2013 1108 1114.e5
    • (2013) Clin Gastroenterol Hepatol , vol.11 , pp. 1108-1114e5
    • Iyer, P.G.1    Borah, B.J.2    Heien, H.C.3
  • 35
    • 3242658023 scopus 로고    scopus 로고
    • Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux
    • M. Solaymani-Dodaran, R. Logan, J. West, and et al. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux Gut 53 2004 1070 1074
    • (2004) Gut , vol.53 , pp. 1070-1074
    • Solaymani-Dodaran, M.1    Logan, R.2    West, J.3
  • 36
    • 39349101029 scopus 로고    scopus 로고
    • Immortal time bias in pharmacoepidemiology
    • S. Suissa Immortal time bias in pharmacoepidemiology Am J Epidemiol 167 2008 492 499
    • (2008) Am J Epidemiol , vol.167 , pp. 492-499
    • Suissa, S.1
  • 37
    • 33947227921 scopus 로고    scopus 로고
    • Immortal time bias in observational studies of drug effects
    • S. Suissa Immortal time bias in observational studies of drug effects Pharmacoepidemiol Drug Safety 16 2007 241 249
    • (2007) Pharmacoepidemiol Drug Safety , vol.16 , pp. 241-249
    • Suissa, S.1
  • 38
    • 84871851757 scopus 로고    scopus 로고
    • The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: A prospective study of Barrett's esophagus
    • S. Hardikar, L. Onstad, P.L. Blount, and et al. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus PloS One 8 2013 e52192
    • (2013) PloS One , vol.8 , pp. e52192
    • Hardikar, S.1    Onstad, L.2    Blount, P.L.3
  • 39
    • 0036784401 scopus 로고    scopus 로고
    • Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: Clinical action thresholds
    • S. Zhu, Z. Wang, S. Heshka, and et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds Am J Clin Nutr 76 2002 743 749
    • (2002) Am J Clin Nutr , vol.76 , pp. 743-749
    • Zhu, S.1    Wang, Z.2    Heshka, S.3
  • 40
    • 84904039736 scopus 로고    scopus 로고
    • Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: A systematic review and meta-analysis
    • S. Singh, S.K. Garg, P.P. Singh, and et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis Gut 63 2014 1229 1237
    • (2014) Gut , vol.63 , pp. 1229-1237
    • Singh, S.1    Garg, S.K.2    Singh, P.P.3
  • 41
    • 20444461067 scopus 로고    scopus 로고
    • Metformin and reduced risk of cancer in diabetic patients
    • J.M. Evans, L.A. Donnelly, A.M. Emslie-Smith, and et al. Metformin and reduced risk of cancer in diabetic patients BMJ 330 2005 1304 1305
    • (2005) BMJ , vol.330 , pp. 1304-1305
    • Evans, J.M.1    Donnelly, L.A.2    Emslie-Smith, A.M.3
  • 42
    • 75149179169 scopus 로고    scopus 로고
    • Metformin associated with lower cancer mortality in type 2 diabetes ZODIAC-16
    • G.W. Landman, N. Kleefstra, K.J. van Hateren, and et al. Metformin associated with lower cancer mortality in type 2 diabetes ZODIAC-16 Diabet Care 33 2010 322 326
    • (2010) Diabet Care , vol.33 , pp. 322-326
    • Landman, G.W.1    Kleefstra, N.2    Van Hateren, K.J.3
  • 43
    • 84924955218 scopus 로고    scopus 로고
    • Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus
    • 665-72.e1-4
    • A. Chak, N.S. Buttar, N.R. Foster, and et al. Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus Clin Gastroenterol Hepatol 13 2015 665-72.e1-4
    • (2015) Clin Gastroenterol Hepatol , vol.13
    • Chak, A.1    Buttar, N.S.2    Foster, N.R.3
  • 44
    • 35148884884 scopus 로고    scopus 로고
    • Barrett's oesophagus: Intestinal metaplasia is not essential for cancer risk
    • C.J. Kelty, M.D. Gough, Q. Van Wyk, and et al. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk Scand J Gastroenterol 42 2007 1271 1274
    • (2007) Scand J Gastroenterol , vol.42 , pp. 1271-1274
    • Kelty, C.J.1    Gough, M.D.2    Van Wyk, Q.3
  • 45
    • 67649538054 scopus 로고    scopus 로고
    • Intestinal differentiation in metaplastic, non-goblet columnar epithelium in the esophagus
    • H.P. Hahn, P.L. Blount, K. Ayub, and et al. Intestinal differentiation in metaplastic, non-goblet columnar epithelium in the esophagus Am J Surg Pathol 33 2009 1006
    • (2009) Am J Surg Pathol , vol.33 , pp. 1006
    • Hahn, H.P.1    Blount, P.L.2    Ayub, K.3
  • 46
    • 65449135220 scopus 로고    scopus 로고
    • Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium
    • W. Liu, H. Hahn, R.D. Odze, and et al. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium Am J Gastroenterol 104 2009 816 824
    • (2009) Am J Gastroenterol , vol.104 , pp. 816-824
    • Liu, W.1    Hahn, H.2    Odze, R.D.3
  • 47
    • 79961022952 scopus 로고    scopus 로고
    • Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: A population-based study
    • K.W. Jung, N.J. Talley, Y. Romero, and et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study Am J Gastroenterol 106 2011 1447 1455
    • (2011) Am J Gastroenterol , vol.106 , pp. 1447-1455
    • Jung, K.W.1    Talley, N.J.2    Romero, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.